CDXS Codexis, Inc. INDUSTRIAL ORGANIC CHEMICALS Best Chemicals Stocks 2026 →

Codexis (CDXS) Stock: Buy, Sell, or Hold?

$0.93
-0.05 (-4.73%) ▼
5d: -8.8% 30d: -27.89% 90d: -40.37%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (57%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$1.08 – $1.37
Position: OVERSOLD
Forward P/E & Valuation
-3.1x CHEAP
vs 16.6x historical avg
Wall Street Target
$6.14
+529.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.90 / $1.24
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CDXS shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When CDXS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CDXS is currently trading at $0.93, which is considered oversold relative to its 30-day fair value range of $1.08 to $1.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.0) compared to its historical average (16.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CDXS is in a strong downtrend. Immediate support is located at $0.90, while resistance sits at $1.24. Short-term momentum is weak, with the stock down 4.7% recently.

Market Sentiment: CDXS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.14 (+529.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.08 - $1.37
Company Quality Score 43/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

Trading Range & Key Levels

30-Day Trading Range $1.08 - $1.37
Current vs Trading Range OVERSOLD
Support Level $0.90
Resistance Level $1.24
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.7%)
  • BULLISH: Trading 529.1% below Wall St target ($6.14)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -3.05
Wall Street Target $6.14 (+529.1%)
Revenue Growth (YoY) -2.7%
Profit Margin -39.6%
PE vs Historical -3.1 vs 16.6 CHEAP
Share CDXS Analysis

Share this live CDXS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CDXS)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 2, 2026
Daily AI digest
AI Retail Discussion Summary: Trader on StockTwits expresses a bullish sentiment towards $CDXS, believing the stock was unfairly punished due to a fake deal announcement.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CDXS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 53 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 50 HOLD
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 37 SELL
RAPP
Rapport Therapeutics, In…
STRONG BUY
16 analysts
$64 48 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CDXS Research Pages
CDXS Technical Chart CDXS Price Prediction CDXS Intrinsic Value DCF CDXS Earnings Date CDXS Investment Advisor CDXS Fair Price Analyzer CDXS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals